Table 1 Comparisons of demographic characteristics and biomarkers between the DMT group and the control group (\(\bar{x}\) ± s).

From: Dance/movement therapy for improving balance ability and bone mineral density in long-term patients with schizophrenia: a randomized controlled trial

Variables

TAU (n = 29)

DMT (n = 29)

t or X2 (p-value)

Dropouts (n = 2)

Finished (n = 58)

t or X2 (p-value)

Age (ys)

55.3 ± 3.9

55.4 ± 3.6

0.31 (0.97)

55.5 ± 2.12

55.3 ± 3.7

0.01 (0.95)

DOI (ys)

34.7 ± 4.3

33.7 ± 4.9

0.75 (0.46)

33.5 ± 3.5

34.2 ± 4.6

0.20 (0.83)

CDD (ys)

7.6 ± 4.4

8.7 ± 6.6

0.71 (0.48)

5.0 ± 1.4

8.1 ± 5.6

0.79 (0.43)

Smokers, n (%)

17 (58.6)

16 (55.2)

0.1 (0.79)

1 (50.0)

33 (56.9)

0.00 (1.00)

Calcium

2.4 ± 0.8

2.4 ± 0.1

0.25 (0.81)

2.2 ± 0.1

2.4 ± 0.1

1.43 (0.16)

BMD

0.41 ± 0.03

0.42 ± 0.03

1.83 (0.07)

0.4 ± 0.01

0.4 ± 0.03

0.48 (0.63)

Berg total score

44.5 ± 6.3

43.1 ± 5.2

0.89 (0.38)

42.0 ± 0.0

43.8 ± 5.8

0.43 (0.67)

Static balance

32.5 ± 3.4

31.5 ± 3.2

1.05 (0.29)

31.0 ± 0.0

32.0 ± 3.3

0.42 (0.68)

Dynamic balance

12.2 ± 3.4

12.2 ± 3.2

0.04 (0.97)

11.0 ± 0.0

12.2 ± 3.3

0.51 (0.61)

  1. ys years, DOI duration of illness, CDD current disease duration, BMD bone mineral density.